Drug Trials Snapshots: ZELSUVMI (berdazimer)

ZELSUVMI is a nitric oxide releasing agent that is indicated for the topical treatment of molluscum contagiosum (MC) in adults and pediatric patients 1 year of age and older. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-zelsuvmi